148 related articles for article (PubMed ID: 29018959)
1. Invariant natural killer T infiltration in neuroblastoma with favorable outcome.
Hishiki T; Mise N; Harada K; Ihara F; Takami M; Saito T; Terui K; Nakata M; Komatsu S; Yoshida H; Motohashi S
Pediatr Surg Int; 2018 Feb; 34(2):195-201. PubMed ID: 29018959
[TBL] [Abstract][Full Text] [Related]
2. Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T-Cell Receptors in High-Risk
Wei JS; Kuznetsov IB; Zhang S; Song YK; Asgharzadeh S; Sindiri S; Wen X; Patidar R; Najaraj S; Walton A; Auvil JMG; Gerhard DS; Yuksel A; Catchpoole D; Hewitt SM; Sondel PM; Seeger R; Maris JM; Khan J
Clin Cancer Res; 2018 Nov; 24(22):5673-5684. PubMed ID: 29784674
[No Abstract] [Full Text] [Related]
3. Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2.
Metelitsa LS; Wu HW; Wang H; Yang Y; Warsi Z; Asgharzadeh S; Groshen S; Wilson SB; Seeger RC
J Exp Med; 2004 May; 199(9):1213-21. PubMed ID: 15123743
[TBL] [Abstract][Full Text] [Related]
4. Frequency and proliferative response of circulating invariant natural killer T cells in pediatric patients with malignant solid tumors.
Hishiki T; Mise N; Harada K; Ihara F; Takami M; Saito T; Terui K; Nakata M; Komatsu S; Yoshida H; Motohashi S
Pediatr Surg Int; 2018 Feb; 34(2):169-176. PubMed ID: 29018953
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of MYCN, DDX1, TrkA, and TrkC gene transcripts expression in neuroblastoma.
de Souza DR; Sanabani SS; de Souza AC; Filho Odone V; Epelman S; Bendit I
Pediatr Blood Cancer; 2011 May; 56(5):749-56. PubMed ID: 21154590
[TBL] [Abstract][Full Text] [Related]
6. Increased Intraepithelial Vα24 Invariant NKT Cells in the Celiac Duodenum.
Montalvillo E; Bernardo D; Martínez-Abad B; Allegretti Y; Fernández-Salazar L; Calvo C; Chirdo FG; Garrote JA; Arranz E
Nutrients; 2015 Oct; 7(11):8960-76. PubMed ID: 26529008
[TBL] [Abstract][Full Text] [Related]
7. Invariant natural killer T cell-based immunotherapy for cancer.
Motohashi S; Nakayama T
Immunotherapy; 2009 Jan; 1(1):73-82. PubMed ID: 20635975
[TBL] [Abstract][Full Text] [Related]
8. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the frequency of invariant natural killer T (iNKT) cells in nasal polyps.
Fereidouni M; Derakhshani A; Yue S; Nasseri S; Farid Hosseini R; Bakhshaee M; Vahidian F; Exley MA
Clin Immunol; 2019 Aug; 205():125-129. PubMed ID: 31152891
[TBL] [Abstract][Full Text] [Related]
10. Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages.
Song L; Asgharzadeh S; Salo J; Engell K; Wu HW; Sposto R; Ara T; Silverman AM; DeClerck YA; Seeger RC; Metelitsa LS
J Clin Invest; 2009 Jun; 119(6):1524-36. PubMed ID: 19411762
[TBL] [Abstract][Full Text] [Related]
11. Efficient Regeneration of Human Vα24
Yamada D; Iyoda T; Vizcardo R; Shimizu K; Sato Y; Endo TA; Kitahara G; Okoshi M; Kobayashi M; Sakurai M; Ohara O; Taniguchi M; Koseki H; Fujii SI
Stem Cells; 2016 Dec; 34(12):2852-2860. PubMed ID: 27422351
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.
Xu Y; Chen X; Lin L; Chen H; Yu S; Li D
Biochimie; 2017 Aug; 139():1-8. PubMed ID: 28456710
[TBL] [Abstract][Full Text] [Related]
13. High expression of the novel endothelin-converting enzyme genes, Nbla03145/ECEL1alpha and beta, is associated with favorable prognosis in human neuroblastomas.
Kawamoto T; Ohira M; Hamano S; Hori T; Nakagawara A
Int J Oncol; 2003 Apr; 22(4):815-22. PubMed ID: 12632073
[TBL] [Abstract][Full Text] [Related]
14. Reevaluation of trkA expression as a biological marker of neuroblastoma by high-sensitivity expression analysis--a study of 106 primary neuroblastomas treated in a single institute.
Hishiki T; Saito T; Terui K; Sato Y; Takenouchi A; Yahata E; Ono S; Nakagawara A; Kamijo T; Nakamura Y; Matsunaga T; Yoshida H
J Pediatr Surg; 2010 Dec; 45(12):2293-8. PubMed ID: 21129533
[TBL] [Abstract][Full Text] [Related]
15. Repp86 expression and outcome in patients with neuroblastoma.
Krams M; Heidebrecht HJ; Hero B; Berthold F; Harms D; Parwaresch R; Rudolph P
J Clin Oncol; 2003 May; 21(9):1810-8. PubMed ID: 12721258
[TBL] [Abstract][Full Text] [Related]
16. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
17. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.
Westermann F; Muth D; Benner A; Bauer T; Henrich KO; Oberthuer A; Brors B; Beissbarth T; Vandesompele J; Pattyn F; Hero B; König R; Fischer M; Schwab M
Genome Biol; 2008 Oct; 9(10):R150. PubMed ID: 18851746
[TBL] [Abstract][Full Text] [Related]
18. Expression of NTRK1/TrkA affects immunogenicity of neuroblastoma cells.
Pajtler KW; Rebmann V; Lindemann M; Schulte JH; Schulte S; Stauder M; Leuschner I; Schmid KW; Köhl U; Schramm A; Eggert A
Int J Cancer; 2013 Aug; 133(4):908-19. PubMed ID: 23400852
[TBL] [Abstract][Full Text] [Related]
19. Shc family expression in neuroblastoma: high expression of shcC is associated with a poor prognosis in advanced neuroblastoma.
Terui E; Matsunaga T; Yoshida H; Kouchi K; Kuroda H; Hishiki T; Saito T; Yamada S; Shirasawa H; Ohnuma N
Clin Cancer Res; 2005 May; 11(9):3280-7. PubMed ID: 15867224
[TBL] [Abstract][Full Text] [Related]
20. Expression of Truncated Neurokinin-1 Receptor in Childhood Neuroblastoma is Independent of Tumor Biology and Stage.
Pohl A; Kappler R; Mühling J; VON Schweinitz D; Berger M
Anticancer Res; 2017 Nov; 37(11):6079-6085. PubMed ID: 29061788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
